| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |